The Series C round was led by a strategic investor and backed by existing supporters to drive international expansion.
"We are delighted to continue backing the ambitious CGD team in bringing groundbreaking GaN technologies to market. As we strive towards a low-carbon future, CGD’s products can deliver higher performance while enabling up to 50% energy savings across multiple growing sectors such as automotive, renewable energy, and data centres. We look forward to seeing the impact that CGD can make in enabling greener power electronics"
The funding round was led by QantX Ventures and will support the development of a rapid prototyping tool for photonic chips.
"The LightCraft platform, in combination with the LightPort, gives businesses the tools to push the boundaries of what’s possible with integrated photonics. Customers can bring their ideas to life quickly and effectively, driven by the expertise of the Light Trace team. At Light Trace, we don’t just design—we build. This hands-on approach provides us with unique insights into the intricacies of photonic chip development, insights that we share with our customers to help fuel their success."
The capital injection will accelerate the silicon roadmap for minimally invasive neural implant applications.
"Our semiconductor-based approach is fundamentally reshaping what neural implants can achieve. By offering a customisable, compact solution that integrates seamlessly into medical devices, we’re empowering a new era of neural interfaces that are not only more powerful but also less invasive. This marks a transformative shift in neurological care."
The Cambridge semiconductor startup secured backing from Octopus Ventures, Cambridge Innovation Capital, BGF, and Foresight Group.
"Securing this Series A funding underscores the strong confidence our investors have in ForeFront RF’s vision and market potential. With continued support from Foresight Group and BGF, and new partnerships with Octopus Ventures and Cambridge Innovation Capital, we’re well-positioned to scale rapidly from engineering prototypes to mass production."
The Scottish laser technology specialist has raised over £1m from existing investors and Innovate UK to fund healthcare product rollouts and emissions monitoring tools.
"Designing and manufacturing state-of-the-art ultrafast infra-red lasers brings huge value and efficiencies to the global healthcare market. Our new '920' builds on a decade of research and IP development to extend our product roadmap."
